344 related articles for article (PubMed ID: 28366453)
1. Genetic Correction of SOD1 Mutant iPSCs Reveals ERK and JNK Activated AP1 as a Driver of Neurodegeneration in Amyotrophic Lateral Sclerosis.
Bhinge A; Namboori SC; Zhang X; VanDongen AMJ; Stanton LW
Stem Cell Reports; 2017 Apr; 8(4):856-869. PubMed ID: 28366453
[TBL] [Abstract][Full Text] [Related]
2. Coactivation of GSK3β and IGF-1 Attenuates Amyotrophic Lateral Sclerosis Nerve Fiber Cytopathies in SOD1 Mutant Patient-Derived Motor Neurons.
Ting HC; Yang HI; Harn HJ; Chiu IM; Su HL; Li X; Chen MF; Ho TJ; Liu CA; Tsai YJ; Chiou TW; Lin SZ; Chang CY
Cells; 2021 Oct; 10(10):. PubMed ID: 34685754
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs.
Wang L; Yi F; Fu L; Yang J; Wang S; Wang Z; Suzuki K; Sun L; Xu X; Yu Y; Qiao J; Belmonte JCI; Yang Z; Yuan Y; Qu J; Liu GH
Protein Cell; 2017 May; 8(5):365-378. PubMed ID: 28401346
[TBL] [Abstract][Full Text] [Related]
4. Induced pluripotent stem cell-derived motor neurons from amyotrophic lateral sclerosis (ALS) patients carrying different superoxide dismutase 1 mutations recapitulate pathological features of ALS.
Liu WC; Liu N; Wang Y; Huang C; Li YF; Wang H; Li XG; Deng M
Chin Med J (Engl); 2021 Oct; 134(20):2457-2464. PubMed ID: 34669638
[TBL] [Abstract][Full Text] [Related]
5. Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons.
Chen H; Qian K; Du Z; Cao J; Petersen A; Liu H; Blackbourn LW; Huang CL; Errigo A; Yin Y; Lu J; Ayala M; Zhang SC
Cell Stem Cell; 2014 Jun; 14(6):796-809. PubMed ID: 24704493
[TBL] [Abstract][Full Text] [Related]
6. MAP4K4 Activation Mediates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis.
Wu C; Watts ME; Rubin LL
Cell Rep; 2019 Jan; 26(5):1143-1156.e5. PubMed ID: 30699345
[TBL] [Abstract][Full Text] [Related]
7. Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations.
Bursch F; Kalmbach N; Naujock M; Staege S; Eggenschwiler R; Abo-Rady M; Japtok J; Guo W; Hensel N; Reinhardt P; Boeckers TM; Cantz T; Sterneckert J; Van Den Bosch L; Hermann A; Petri S; Wegner F
Hum Mol Genet; 2019 Sep; 28(17):2835-2850. PubMed ID: 31108504
[TBL] [Abstract][Full Text] [Related]
8. Single-cell transcriptomics identifies master regulators of neurodegeneration in SOD1 ALS iPSC-derived motor neurons.
Namboori SC; Thomas P; Ames R; Hawkins S; Garrett LO; Willis CRG; Rosa A; Stanton LW; Bhinge A
Stem Cell Reports; 2021 Dec; 16(12):3020-3035. PubMed ID: 34767750
[TBL] [Abstract][Full Text] [Related]
9. Downstream Effects of Mutations in
Dash BP; Freischmidt A; Weishaupt JH; Hermann A
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077049
[TBL] [Abstract][Full Text] [Related]
10. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.
Coatti GC; Frangini M; Valadares MC; Gomes JP; Lima NO; Cavaçana N; Assoni AF; Pelatti MV; Birbrair A; de Lima ACP; Singer JM; Rocha FMM; Da Silva GL; Mantovani MS; Macedo-Souza LI; Ferrari MFR; Zatz M
Stem Cell Rev Rep; 2017 Oct; 13(5):686-698. PubMed ID: 28710685
[TBL] [Abstract][Full Text] [Related]
11. 4-Aminopyridine Induced Activity Rescues Hypoexcitable Motor Neurons from Amyotrophic Lateral Sclerosis Patient-Derived Induced Pluripotent Stem Cells.
Naujock M; Stanslowsky N; Bufler S; Naumann M; Reinhardt P; Sterneckert J; Kefalakes E; Kassebaum C; Bursch F; Lojewski X; Storch A; Frickenhaus M; Boeckers TM; Putz S; Demestre M; Liebau S; Klingenstein M; Ludolph AC; Dengler R; Kim KS; Hermann A; Wegner F; Petri S
Stem Cells; 2016 Jun; 34(6):1563-75. PubMed ID: 26946488
[TBL] [Abstract][Full Text] [Related]
12. Targeting low levels of MIF expression as a potential therapeutic strategy for ALS.
Alfahel L; Gschwendtberger T; Kozareva V; Dumas L; Gibbs R; Kertser A; Baruch K; Zaccai S; Kahn J; Thau-Habermann N; Eggenschwiler R; Sterneckert J; Hermann A; Sundararaman N; Vaibhav V; Van Eyk JE; Rafuse VF; Fraenkel E; Cantz T; Petri S; Israelson A
Cell Rep Med; 2024 May; 5(5):101546. PubMed ID: 38703766
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic Insights of Astrocyte-Mediated Hyperactive Autophagy and Loss of Motor Neuron Function in SOD1
Rajpurohit CS; Kumar V; Cheffer A; Oliveira D; Ulrich H; Okamoto OK; Zatz M; Ansari UA; Khanna VK; Pant AB
Mol Neurobiol; 2020 Oct; 57(10):4117-4133. PubMed ID: 32676988
[TBL] [Abstract][Full Text] [Related]
14. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
[TBL] [Abstract][Full Text] [Related]
15. Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS.
Luisier R; Tyzack GE; Hall CE; Mitchell JS; Devine H; Taha DM; Malik B; Meyer I; Greensmith L; Newcombe J; Ule J; Luscombe NM; Patani R
Nat Commun; 2018 May; 9(1):2010. PubMed ID: 29789581
[TBL] [Abstract][Full Text] [Related]
16. Aberrant axon branching via Fos-B dysregulation in FUS-ALS motor neurons.
Akiyama T; Suzuki N; Ishikawa M; Fujimori K; Sone T; Kawada J; Funayama R; Fujishima F; Mitsuzawa S; Ikeda K; Ono H; Shijo T; Osana S; Shirota M; Nakagawa T; Kitajima Y; Nishiyama A; Izumi R; Morimoto S; Okada Y; Kamei T; Nishida M; Nogami M; Kaneda S; Ikeuchi Y; Mitsuhashi H; Nakayama K; Fujii T; Warita H; Okano H; Aoki M
EBioMedicine; 2019 Jul; 45():362-378. PubMed ID: 31262712
[TBL] [Abstract][Full Text] [Related]
17. Analysis of proteome-wide degradation dynamics in ALS SOD1 iPSC-derived patient neurons reveals disrupted VCP homeostasis.
Tsioras K; Smith KC; Edassery SL; Garjani M; Li Y; Williams C; McKenna ED; Guo W; Wilen AP; Hark TJ; Marklund SL; Ostrow LW; Gilthorpe JD; Ichida JK; Kalb RG; Savas JN; Kiskinis E
Cell Rep; 2023 Oct; 42(10):113160. PubMed ID: 37776851
[TBL] [Abstract][Full Text] [Related]
18. Differentiation but not ALS mutations in FUS rewires motor neuron metabolism.
Vandoorne T; Veys K; Guo W; Sicart A; Vints K; Swijsen A; Moisse M; Eelen G; Gounko NV; Fumagalli L; Fazal R; Germeys C; Quaegebeur A; Fendt SM; Carmeliet P; Verfaillie C; Van Damme P; Ghesquière B; De Bock K; Van Den Bosch L
Nat Commun; 2019 Sep; 10(1):4147. PubMed ID: 31515480
[TBL] [Abstract][Full Text] [Related]
19. ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissues.
Bayer H; Lang K; Buck E; Higelin J; Barteczko L; Pasquarelli N; Sprissler J; Lucas T; Holzmann K; Demestre M; Lindenberg KS; Danzer KM; Boeckers T; Ludolph AC; Dupuis L; Weydt P; Witting A
Neurobiol Dis; 2017 Jan; 97(Pt A):36-45. PubMed ID: 27818323
[TBL] [Abstract][Full Text] [Related]
20. Amyotrophic lateral sclerosis models derived from human embryonic stem cells with different superoxide dismutase 1 mutations exhibit differential drug responses.
Isobe T; Tooi N; Nakatsuji N; Aiba K
Stem Cell Res; 2015 Nov; 15(3):459-468. PubMed ID: 26413785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]